The use of biocatalysts, including enzymes and metabolically engineered cells, has attracted a great deal of attention in chemical and bio-industry, because biocatalytic reactions can be conducted under environmentally-benign conditions and in more sustainable ways. The catalytic efficiency and chemo-, regio-, and stereo-selectivity of enzymes can be enhanced and modulated using protein engineering. Metabolic engineering seeks to enhance cellular biosynthetic productivity of target metabolites via controlling and redesigning metabolic pathways using multi-omics analysis, genome-scale modeling, metabolic flux control, and reconstruction of novel pathways.
Several investigations in this issue focused on the development of immobilization methods for better biocatalytic performance. By using mannose-functionalized magnetic nanoparticles, Li et al. successfully immobilized E. coli cells harboring recombinant glycerol dehydrogenase gene, which showed two-fold higher production of 1,3-dihydroxyacetone from glycerol, compared to the free cells [7] . An optimized procedure of fluorescein diacetate hydrolysis for quantifying total enzymatic activity in the whole biofilm on the carrier without disturbing immobilization was reported by Dzionek et al., which can serve as a promising method to evaluate the physiological state of immobilized bacterial cells [8] . Additionally, Arana-Peña et al. reported the immobilization of Eversa lipase on octyl and aminated agarose beads for the first time, which greatly enhanced the stability of the enzyme [9] . The immobilized enzymes prepared by the cross-linked enzyme aggregates (CLEA) have become more attractive due to their simple preparation and high catalytic efficiency. In this issue, the magnetic cross-linked aggregates of amyloglucosidase was successfully achieved by Amaral-Fonseca et al. [10] . Especially the conditions or factors for the preparation of combi-CLEAs, such as the proportion of enzymes, the type of cross-linker, and coupling temperature, were intensively reviewed by Xu et al. [11] .
The last part of this special issue focuses on metabolic engineering of various microorganism for the production of value-added products. Kim et al. reported the enhancement of (-)-α-bisabolol productivity by creating a more efficient heterologous mevalonate pathway [12] . An engineered E. coli strain for the conversion of acetate to 3-hydroxypropionic acid by heterologous expression of malonyl-CoA reductase from Chloroflexus aurantiacus and the activation of acetate assimilating pathway and glyoxylate shunt pathway was developed by Lee et al. [13] . Baritugo et al. developed a novel tunable promoter system based on repeats of the Vitreoscilla hemoglobin promoter and subsequently used for 5-aminovaleric acid and gamma-aminobutyric acid production in several C. glutamicum strains [14] . Three intensive reviews on various aspects on metabolic engineering have been published in this issue. Xie et al. highlighted insights into the current advances of monoterpene bioproduction and future outlook to promote the industrial production of valuable monoterpenes [15] . Recent advances in synthetic biology are greatly useful for achieving metabolic engineering purposes, which have been intensively reviewed by Lee et al. [16] . The technological gaps and effective approaches for process intensification of bio-hydrogen production were reviewed by Sun et al., particularly on the latest methods of chemicals/metal addition for improving hydrogen generation during dark fermentation processes [17] . Furthermore, this special issue includes the investigation on mass transfer performance of a novel string film reactor for the aerobic conversion of methane gas, investigated by Mariyana et al., to address process intensification issue on biomanufacturing [18] .
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